PharmAla Biotech Holdings, Inc. (TSE:MDMA) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmAla Biotech Holdings Inc. has launched a new online tool to streamline MDMA research by providing researchers with easy access to essential drug data and quality information. This innovation is expected to facilitate the application process for clinical trials and boost the company’s clinical trial sales pipeline. Additionally, PharmAla announced the appointment of William Avery as the new CFO, replacing the outgoing Carmelo Marelli.
For further insights into TSE:MDMA stock, check out TipRanks’ Stock Analysis page.